Post by
Gman620 on Sep 03, 2021 1:25pm
Short Term Execution is Key
Can they sell their software/methods system and enough synthetic Ibogaine to at least get good terms for the next financing round? It's hard to buy this when another dilution is probably coming. They don't have much cash left. I'm pulling for them, but it gets down to some crisp execution in the very short term.
Comment by
Bluebron on Sep 13, 2021 8:42pm
How many times have they diluted their shares and by what quantity?